Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
206 Cards in this Set
- Front
- Back
Periodontal Clinical Evaluation
|
Visual: Gingival color, contour, texture and amt
Indices: Plaque and Bleeding Probing Furcation involvement tooth mobility/occlusion |
|
Perio Diagnostic Information
|
Patient Interview
Clinical Examination Radiographic Examination Specialized testing |
|
Fenestration
|
hole in the bone
|
|
Dehiscense
|
if the bridge of bone is gone- v-shaped
|
|
alveolar bone resorption and formation of periodontal defects
|
necessary to open a flap to see what is going on here
|
|
Hormonal Complications
|
1. Pregnancy gingivitis
2. Birth control pill induced gingivitis 3. Puberty gingivitis 4. Gingivitis menstrualis & intermenstualis |
|
Pregnancy Gingivitis (Etiology)
|
-Estrogen & progesterone show higher gingival concentrations (second major cause)
-Induce changes in vascular permeability & gingival fluid flow (gingival edema & increased inflammatory response to dental plaque) -Steroid hormones can also stimulate the growth of certain periodontal pathogens (Prevotella intermedia) -PLAQUE is the MAJOR cause of pregnancy gingivitis |
|
Pregnancy Gingivitis (Clinical appearance)
|
1) Marginal enlargement
2) Tumorlike gingival enlargement |
|
Pregnancy Gingivitis (Marginal Enlargement)
|
-Swollen, red gingiva with enlarged papillae, increased BOP
-Clinically present especially between 2nd & 8th months of pregnancy -Treatment: meticulous oral hygiene throughout pregnancy |
|
Pregnancy Gingivitis (Tumorlike Gingival Enlargment)
|
-Pregnancy Granuloma (variant of pyogenic granuloma) --> Not a neoplasm, but an INFLAMMATORY RESPONSE
-Benign, bright red, friable polypoid papule/nodule ranging from a few mm to several cm. -Often bleeding, erosion, ulceration, & crusting -Regressing lesions appear as soft fibroma -Frequent along the maxillary mucosal surface -Occurs in 5% of pregnancies (2nd or 3rd trimester) -Granuloma grows rapidly to its maximum size over a few weeks -High RECURRENCE rate -Often REGRESSES after pregnancy -Treatment: try to remove & closely monitor. Must be removed if impairing function |
|
Oral Contraceptives
|
-Hormonal changes induced by contraceptives could cause increased gingivitis, also "pregnancy granuloma"
-Vascular permeability & exudation is increased by contraceptives containing progesterone |
|
Puberty Gingivitis
|
-Varying HORMONE LEVELS promote gingival inflammatory & proliferative responses to local factor (plaque)
-Changes in the subgingival microbiotic -Treatment: good oral hygiene |
|
Medicament-Elicited Overgrowth
|
1. Phenytoin-induced gingival overgrowth
2. Nifedipine-induced gingival overgrowth 3. Cyclosporine-induced gingival overgrowth 4. Medicament combination (cyclosporine/nifedipine) |
|
Phenytoin (Dilantin)-Induced Gingival Overgrowth
|
-Anticonvulsant --> used for treatment of epilepsy
-Gingival enlargement observed in 50% of pts --> occurs after a threshold level has been exceeded (not dose-dependent) -Tends to occur in younger pts -Etiology: 1. Genetically predetermined subpopulations of fibroblasts (increased collagen) 2. Inactivation (decrease) of collagenase (less destruction of collagen) 3. Plaque-induced inflammation |
|
Phenytoin-Induced Gingival Overgrowth (Therapy)
|
-Adequate oral hygiene
-Plaque & calculus removal -Once inflammation subsides, fibrous tissue can be excised (gingivectomy & gingivoplasty) -High recurrence rate |
|
Radiographic Information for Diagnosing Periodontal Disease
|
-presence, extent, distribution, and pattern of alveolar bone loss
-furcation invasions -widening of periodontal ligament (PDL) -calculus detection -confounding tooth anatomy or restorative factors |
|
Panoramic Radiograph
|
Not the best for perio because cannot really tell bone levels around tooth
lose detail good for tooth position and assesing position of mandibular canal cannot see caries around crowns |
|
Dihydropyridine (Nifedipine)-Induced Gingival Overgrowth
|
-Calcium channel blocker --> reducing the influx of calcium ions into heart muscle
-Reduces the strength of contraction & vascular resistance -Reduces oxygen consumption -Both anti-anginal & anti-hypertensive effects |
|
Dihydropyridine-Induced Gingival Overgrowth (Therapy)
|
-Adequate oral hygiene
-Plaque & calculus removal -Gingivectomy & Gingivoplasty, as needed |
|
Cyclosporine-Induced Gingival Overgrowth
|
Immunosuppressive agent (often organ transplant pts):
-Suppression of antibody formation against T-cell-dependent antigens -Suppression of cell-mediated immunity -Interference with production of cytokines Side effects: -Nephrotoxicity -Hypertension -Hypertrichosis |
|
Cyclosporine-Induced Gingival Overgrowth (Therapy)
|
-Motivation, OHI
-Initial periodontal therapy -Possible gingivectomy & gingivoplasty |
|
Types of Gingival Overgrowth (Tumors)
|
1. Epulis
2. Idiopathic & hereditary fibrosis 3. Neoplasms (Benign/Malignant Tumors) |
|
Epulis (Benign Tumors)
|
Generic term that clinically designates all discrete tumors & tumorlike masses of the gingiva
|
|
Epulis (Types)
|
1. Pyogenic granuloma
2. Giant cell epulis 3. Fibrous epulis -Pyogenic granuloma & giant cell epulis can develop quickly; the fribrous epulis develops rather slowly -Unknown etiology, possible marginal irritation |
|
Pyogenic Granuloma - Epulis
|
-Localized, tumor-like bright red
-Usually seen in papillary area -When probed, copious mix of blood & pus -Treatment = simple EXCISION |
|
Giant cell Epulis
|
-"Peripheral giant cell granuloma"
-Often resembles a pyogenic granuloma -TREATMENT = Excision, Gingival flap, Tooth & root surfaces planned, Bone filed -High recurrence rate (must scrape surface of bone to be sure no giant cell is left behind) |
|
Fibrous Epulis
|
-Localized, fibrous, firm mass
-Treatment: SIMPLE EXCISION |
|
Periapical Radiograph
|
a lot of detail great for bone loss
|
|
prescense of alveolar bone loss
initial lesion |
loss of crestal lamina dura
funeling or widening of coronal periodontal ligament space |
|
Presence of alveolar bone loss
established lesion |
apical migration of the alveolar crest greater than 2mm from the cemento-enamel junction (CEJ)
|
|
Slight alveolar bone loss
|
apical migration of the alveolar crest within the coronal third of the root length
|
|
moderate alveolar bone loss
|
apical migration of the alveolar crest within the middle third of the root length
|
|
severe alveolar bone loss
|
apical migration of the alveolar crest within the apical third of the root length
|
|
percent alveolar bone loss
|
relative to root length
so if you have short length a couple of mm could mean 50% bone loss |
|
Root anatomy and alveolar bone support
|
easier to treat and maintain a single rooted tooth than a multi rooted tooth
furcation involvements happen with multi rooted teeth (more difficult to clean and more challenging to treat) |
|
Radiographically radiolucency in the furcation area
|
automatically place the patient in a more advanced bone loss category because the furcation is more difficult to treat and maintain
|
|
Clinical Crown to Root Ratio
|
don't know how much structure is left around a tooth, trace a straight line from incisal edge of crown to there the bone is
straight line from bone to apex |
|
level of the radiographic alveolar bone crest and its relation to the CEJ will correspond to the anatomic crest when
|
-x-ray beam is directed perpendicular to the alveolar bone
-the film is positioned parallel to the long axis of the tooth |
|
Distribution of alveolar bone loss
|
-generalized: homogeneous throughout the dentition
-localized: heterogeneous throughout the dentition and restricted to isolated teeth |
|
Pattern of alveolar bone loss
|
horizontal and vertical
|
|
Horizontal bone loss
|
interproximal bone destruction which is parallel with the line intersecting adjacent CEJS
|
|
Vertical bone loss
|
interproximal bone destruction which is not parallel with the line intersecting adjacent CEJs
Intrabony or vertical osseous defect formation |
|
Furcation invasions
|
-radiolucent lesion at the site of root divergence of a multi-rooted tooth
initial widening of furcation periodontal ligament space furcation lesions classified clinicaly (e.g., class I, II and III) and not radiographically |
|
Calculus detection
|
can be done radiographically
|
|
Widening of periodontal ligament (PDL) space
|
-coronal versus apical widening
-initial lesion (interproximal or furcal) - sign of trauma from occlusion |
|
radiographic signs of trauma from occlusion
|
widened PDL space
thickenining of lamina dura root resorption (external hypercementosis root fracture pulpal calcifications |
|
trauma from occlusion
|
-may be a destructive cofactor in periodontitis
-primary: increased occlusal forces (parafunctional or iatrogenic) superimposed on a normal periodontium -secondary: normal forces superimposed on a compromised or reduced periodontium |
|
Idiopathic & hereditary fibrosis
|
1. Fibrosis (may be CT, bone, or both)
2. Exostosis (increased bulkiness at the apices) 3. Papilloma, gingival cysts Treatment: -Excision of soft tissue growth -Osseous thickening may require osteoplasty -Combination thereof Recurrences are frequent |
|
Malignant Tumors
|
1. Carcinoma (Most common)
2. Melanoma -Sarcoma -Oral carcinoma = 1-5% of all carcinomas -Malignant tumors are VERY RARE in gingiva -Gingiva might be site for metastases |
|
Malignant Tumors
(Therapy) |
-Clinical Diagnosis
-Biopsy & frozen-section diagnosis -Radical surgical removal, Chemotherapy, & Radiotherapy |
|
Pemphigoid
|
Mucous membrane pemphigoid --> Ag-Ab complexing occurs at the BASEMENT MEMBRANE & CT, followed by complement activation & subsequent leukocyte recruitment
-Epithelium comes off when rubbed with gauze (exposes CT & is painful) -Ocular lesions (Symblepharon; Ankyloblepharon) -Oral lesions (Desquamative gingivitis, Erythema, Ulceration, Vesiculation) |
|
Pemphigoid
(Therapy) |
-Symptomatic therapy (pain control)
-In more involved cases, topical & systemic corticosteroid preparations might be indicated -Optimal oral hygiene -CT grafts |
|
Epidermolysis bullosa
|
-Generalized desquamating condition of the skin & mucosa with associated scarring, contractures & dental defects
-Similar ot bullous & mucous membrane pemphigoid -Oral: teeth exhibit delayed eruption & enamel hypoplasia with rapid caries development -Immune reactivity at the basement membrane zone |
|
Pemphigus Vulgaris
|
-Autoimmune bullous disorders that produce cutaneous & mucous membrane blisters
-More serious condition -EPITHELIUM layer sloughs, leaving painful & expanded erosions (Not between the epithelium & the CT) -Cell-to-cell adhesion structures are damaged by the action of circulating & in vivo binding of auto-antibodies to the pemphigus vulgaris antigens |
|
Pemphigus Vulgaris
(Therapy) |
-Immunosuppressive drugs & systemic corticosteroids
-Prognosis is relatively poor |
|
Lichen Planus
|
-Skin & mucosal alterations
-Relatively frequent -Morbidity: 0.2-1.9% of adult population -Milky-white, pebbly, hyperkeratotic, net-like coatings (Atrophic, may subsequently erode) |
|
Types of Lichen Planus
|
Reticular
Erosive Patch Atrophic Bullous |
|
confounding tooth anatomy or restorative factors
|
-root length
-root form (conical versus bulbous;dilacerations) -root divergence and proximity -crown:root ratio -caries and/or restorative margin quality (open or overhanging restorations) |
|
limitations of radiogrphs
|
- 2D images representing 3D anatomic structure
- do not show Perio pockets - do not distingish between successfully treated and untreated cases - do not record morphology/pattern of bony defects - do not show the facial/labial or lingual/palatal of tooth - no soft-to-hard-tissue relationships - do not record tooth mobility |
|
Screening
radiographs needed |
four, posterior vertical bitewing radiographs
|
|
comprehensive examination
radiographs needed |
full mouth series (>18 intraoral films); limited diagnostic information from panoramic films
|
|
Recall
radiographs needed |
vertical bitewing radiographs or select periapical films
- frequency: depends on overall patient risk for progressive disease, but in general every 2-3 years or longer |
|
Lichen Planus
(Therapy) |
-No true causal therapy
-Monitoring -Erosive forms might require local and/or systemic corticosteroids |
|
Erythema multiforme
(Etiology & Clinical appearance) |
Etiologic factors:
1. Herpes simplex infection 2. Mycoplasma infection 3. Drug reactions Oral lesions --> multiple, large shallow, painful ulcers with an erythematous border (on buccal mucosa, tongue) |
|
Erythema multiforme
(Therapy) |
-Resolve spontaneously
-Mild: antihistamines, topical anesthetics -Severe: corticosteroids |
|
Leukoplakia
(Pre-Cancerous Lesions) |
-White spots that cannot be classified as any other kind of lesion, unrelated, except for the use of tobacco (NOT a diagnosis)
-Smokers 3X mor elikely to exhibit leukoplakia -Etiology unknown -Secondary infection & malignant formation |
|
Leukoplakia
(Therapy) |
-Observation/monitoring
-Retinoids -Surgery if malignancy suspected |
|
Erythroplakia
|
-A CLINICAL term for a red patch of the oral mucosa
-Frequently caused by epithelial dysplasia, carcinoma in situ, or squamous cell carcinoma -ALWAYS BIOPSY |
|
Diagnosis of Active or Progressive alveolar bone loss
|
-requires two radiographic examinations separated in time but similar projection and angulations
-approximately 30% of bone mineral must be lost for visual detection - computer-assisted digital radiography for increased sensitivity of detection |
|
Systemic Treatment
|
medical consultation and pre-medication
|
|
Acute Treatment
|
emergency treatement of pain and/or infection
|
|
Disease Control Phase
|
Initial therapy (scaling and root planing, OHI, removal of caries, antimicrobial therapy, occlusal therapy, minor orthodontic movement, etc)
|
|
Reevaluation of Initial Therapy
|
(4-8 weeks after last quadrant of ScRP): probing depths, check for gingival inflammation
|
|
jDefinitive Phase
|
Surgical treatment- including placement of implants
|
|
Reevalution of surgical phase
|
6 wks-6 months after last surgery
|
|
Restorative phase
|
final restorations, fixed and/or removable appliances etc
|
|
Maintanance phase
|
(long term care q 3 mo or according to plaque control)
|
|
preferred sequence of perio therapy
|
emergency phase-->
non surgical phase --> maintenance phase --> to either surgical or restorative |
|
explaining tx plan to pt
|
be specific
avoid vague statements begin your discussion on a positive note always try to present the treatment plan entirely, as a unit, as much as possible |
|
doing nothing is not advisable
|
periodontal diseases are infections with systemic implications
restorations cannot be done until perio is treated and maintained perio may lead to tooth loss and bone loss and makes it difficult to replace teeth |
|
Herpetic Gingivostomatitis
|
-Viral infection (HSV-1), contagious
-Painful -Acute gingivitis with blister-like aphthae, erosive lesions on attached gingiva (oral mucosa, lips) -Vesicles --> Ulcers (red, elevated, halo-like margin) -Course of disease is 7-10 days |
|
Herpetic Gingivostomatitis
(Predisposing Factors) |
Mechanical trauma
Sun exposure Inadequate diet Hormonal disturbances Stress |
|
Herpetic Gingivostomatitis
(Therapy) |
-Topical application of PALLIATIVE ointments, antimicrobial rinse
-Acyclovir systemically & topically -In severe forms - antibiotic tx -Often healing spontaneously within 1-2 weeks without any therapy |
|
Diabetes Mellitus
(Type I) |
-"Early-onset" - IDDM
-Accounts for ~10% of all diabetes cases -Most common in youth -Due to destruction of the insulin producing beta-cells via an autoimmune process in susceptible individuals -Treatment by insulin injections |
|
Diabetes Mellitus
(Type II) |
-"Adult onset" - NIDDM
-Accounts for 90% of diabetes cases -Milder form with GRADUAL onset -Most patients are OBESE -Results from combination of resistance to insulin & an insulin secretory defect -May require exogenous insulin or oral hypoglycemic drugs during periods of stress for acute hyperglycemia -May be seen in FAMILY AGGREGATION as an autosomal dominant trait |
|
Diabetes Mellitus
(Symptoms) |
Polyuria
Polyphagia Polydypsia |
|
Diabetes Mellitus
(Complications) |
Retinopathy
Nephropathy Neuropathy Circulatory abnormalities |
|
How might Diabetes affect the Periodontium?
|
-Vascular changes
-Impaired collagen metabolsim -Advanced Glycation End-products (AGEs) formation -Increased GCF glucose -Impaired host defense |
|
Effect of Periodontal Treatment on Metabolic Control of Diabetes (Mechanical Treatment Only)
|
-Treatment had NO EFFECT on level of Blood Glucose or HbA1c
-Treatment reduced Probing Depths & increased CAL. No effect on HbA1c or serum glucose. |
|
Effect of Periodontal Treatment on Metabolic Control of Diabetes (Mechanical Treatment AND Systemic Antibiotics)
|
-Treatment reduced PD and HbA1c.
-These results support the hypothesis that anti-inflammatory therapy can help in metabolic control of diabetes |
|
Ascorbic acid (Vitamin C) deficiency
|
-Marginal gingival enlargement
-Hemorrhage -Collagen degeneration (Spontaneous tooth loss; Collagen fibers of the PDL may be defective - severe periodontal disease) Edema of the gingival connective tissue Presence of plaque results in exaggerated inflammation Treatment = MOST symptoms are REVERSED by adequate dietary intake of ascorbic acid (EXCEPT the periodontal damage) |
|
Down Syndrome
|
-Trisomy 21
-Periodontal destruction exceeds that explainable by local factors alone (Poor PMN chemotaxis & phagocytosis; Increased #s of P. intermedia) -Deep periodontal pockets -Generalized; severe bone loss in mand. anteriors -High frenum attachment -Recession |
|
Papillon-Lefevre Syndrome
|
-Rare autosomal recessive dermatologic disease
-Severe periodontitis & hyperkeratosis (palms & soles of feet) -Deciduous teeth are lost prematurely -Permanent teeth ALWAYS periodontally involved) Therapy: -Aggressive treatment including extraction of deciduous teeth & some permanent teeth has shown some success in maintaining residual permanent teeth (Outcome of periodontal therapy is unpredictable) |
|
Chediak-Higashi Syndrome
|
-Rare genetic disease, autosomal recessive trait
-Abnormalities in the cytoplasmic granules result in impaired killing of certain microorganisms -Reduced functional capacity of the PMN -Partial albinism, mild bleeding disorders, recurrent bacterial infections -Aggressive periodontitis |
|
Genetically-elicited Systemic Syndromes
|
Down Syndrome
Papillon-Lefevre Syndrome Chediak-Higashi Syndrome |
|
Hematological Diseases
|
Leukemia
Cyclic neutropenia Agranulocytosis Thrombocytopenia Anemia |
|
Leukemia
|
-Overproduction of WBCs; many appear in immature form in the blood
-Acute, subacute & chronic forms |
|
Leukemia (Clinical Features)
|
-Acute form --> malaise, fever, lympahdenopathy, petechiae or ecchymoses of skin or mucous membranes
-GENERALIZED GINGIVAL ENLARGEMENT is a common feature, especially in acute form -Infiltration of gingiva with leukemic cells is observed in acute leukemias, esp. monocytic -Also Gingivitis, Gingival Bleeding, Oral Ulcerations, & Petechiae are common |
|
Neutropenia
|
-A decrease in circulating NEUTROPHILS in the peripheral blood
-Patients often present with infections -Oral mucosa should be examined for apthous ulcers, candidiasis, or forms of periodontal diseases |
|
Neutropenia
(Severity Categories) |
MILD - with an ANC (Absolute Neutrophil Count) of 1000-1500 cells/mm3
MODERATE - with an ANC of 500-1000 cells/mm3 SEVERE - with an ANC of <500 cells/mm3 AGRANULOCYTOSIS - <100 cells per microliter (Very susceptible to infections) |
|
Cyclic Neutropenia
(Clinical Appearance) |
-Periodic neutropenia with subsequent infections, followed by peripheral neutrophil count recovery
-Infants or children -Prognosis good with benign course |
|
Thrombocytopenia
|
-Abnormal reduction in the number of circulating BLOOD PLATELETS
Etiology: -Idiopathic -Might develop secondary to a variety of systemic conditions, infections or medications Oral Features: -Mild to severe Gingival Hemorrhage, often unprovoked -Petechiae or ecchymoses might be seen in oral mucosa -Risk of periodontal surgery = Decreased blood clot formation |
|
Anemia
|
-Abnormal reduction in circulating RED BLOOD CELLS
Clinical features - variety of manifestations depending on type of anemia: -weakness, fatigability, dizziness, weight loss, pallor, shortness of breath, numbness & tingling of extremities Oral Manifestations: -Glossitis, atrophy of tongue papillae, burning sensation of tongue -Gingival hemorrhage may occur |
|
Immune Deficiency
|
HIV Infection:
-Fungal infections -Bacterial infections -Viral infections -Neoplasms CANDIDIASIS is the MOST COMMON oral lesion in HIV disease and has been found in ~90% of AIDS patients -Pseudomembranous -Erythematous -Hyperplastic candidiasis -Angular cheilitis |
|
Pseudomembranous candidiasis
(Therapy) |
-Removal of membrane
-Local & Systemic Antifungals Fungal Infection in HIV |
|
Atrophic, Erythematous candidiasis
(Therapy) |
-Topical Chlorihexidine
-Antimycotic Diflucan Fungal Infection in HIV |
|
Linear Gingival Erythema (LGE)
(Therapy) |
-Mechanical cleaning
-Iodine subG irrigation -CHX rinses -OHI Fungal Infection in HIV -Candida species? |
|
Necrotizing Ulcerative Gingivitis (NUG)
(Therapy) |
-Debridement
-CHX rinse -Metronidazole, amoxicillin Bacterial Infection in HIV |
|
Necrotizing Ulcerative Periodontitis (NUP)
(Therapy) |
Metronidazole: 250mg with 2 tabs taken immediately and then 1 tab 4X daily for 5-7 days
Bacterial Infection in HIV |
|
Herpetic Stomatitis
(Therapy) |
-Topical analgesics
-Systemic acyclovir -Anti-inflammatory Viral Infection in HIV |
|
Viral Infection in HIV
|
Herpetic Stomatitis
Human Papilloma Virus |
|
Fungal Infection in HIV
|
Pseudomembranous candidiasis
Atrophic, Erythematous candidiasis Linear Gingival Erythema (LGE) |
|
Bacterial Infection in HIV
|
Necrotizing Ulcerative Gingivitis
Necrotizing Ulcerative Periodontits |
|
Neoplasms in HIV
|
Kaposi Sarcoma
|
|
Kaposi Sarcoma
|
-Angiosarcoma of endothelium of blood & lymph vessels
-Flat or exophytic -Painless -In 10-20% of ALL HIV cases (in the past; not as common today) |
|
Prognosis Definition
|
act of foretelling the duration, course result and termination of a disease.
*depends on correctness/accuracy of diagnosis |
|
Short Term Prognosis
|
Less than or equal to 5 years
|
|
Long Term Prognosis
|
Greater than 5 years
|
|
Factors Affecting Prognosis of the Dentition
|
Patient attitudes and Desires
Age General Health Control of Etiology Strategic Teeth Oral Hygiene Economics Operator Ability |
|
Factors Affecting Prognosis of an Individual Tooth
|
Osseous support
Root anatomy Crown-Root Ratio Rate of Attachment loss Mobility Importance of tooth Knowledge and skill of therapist |
|
Factors Affecting General Prognosis
|
Systemic factors/health
Plaque (quantity and composition) Calculus Smoking Iatrogenic Factors Genetics Occlusion? |
|
Evaluation Process Patient Factors
|
Health
Behaviors exposures genetics |
|
Evaluation Oral Problem List
|
decay
perio disease recession excessive gingival display edentulism trauma |
|
Evaluation Process
|
Posterior dentition VS esthetic zone (esthetic risk)
gingival biotype (thin, thick) Presence of inflammation Crestal bone levels (perio disease, furcation involvement) |
|
Decision Making Process
|
Can tooth/teeth be restored
Treatment Planning Costs Esthetic concerns Compliance |
|
Is a smooth surface needed?
|
-Soft tissue healing response
-Junctional epithelium readpts to root surface after SRP in uneven root surfaces -Ultrasonic instrumentation is considered the best instrument for SRP in furcation areas |
|
Ultrasonic
|
2 Types:
-Magnetostrictive --> elliptic vibration -Piezoelectric --> linear vibration -Vibrations are produced by a metal core, which can change dimension in an electromagnetic field with an operating frequency between 25,000 & 45,000 cycles/sec (Hz) -Heat is produced during use & needs a coolant -Sonic & piezoelectric generate less heat than Magenetostrictive -Water cools frictional heat only & helps flush away debris |
|
Ultrasonic
(Advantages) |
-Reduction of time & fatigue
-All aspects of the tip work -Uses water for cooling & lavage -Improved access to areas such as furcations -TF 10 (Black) for heavy calculus removal -Slim-line (Green) for finishing & access |
|
Sonic
|
-Sonic is AIR driven & vibrations are generated mechanically
-Vibrations of 2,000-6,500 cycles/sec (Hz) -Some sonic scalers shown to be as effective for calculus removal as the ultrasonic -Sonic scaler caused less root surface roughness than the ultrasonic |
|
Laser Instruments
|
-Lack of evidence that this technology offers true advantage when compared to traditional methods
|
|
Factors to Consider in Determining a Prognosis
|
Overall clinical factors
Systemic and Environmental factors Local Factors Prosthetic and Restorative Factors |
|
Air Polishing
|
-Air-powered slurry of warm water & sodium bicarbonate
-Ideal for extrinsic stain removal & soft deposits -Tooth structure can be lost & gingival tissue injury can occur if improperly used -Other powder: aluminum trihydroxide -Recommend a pre-procedural rinse with 0.12% chlorhexidine gluconate to minimize the microbial content aerosol -High-speed evacuation should always be used |
|
Overall Clinical Factors
|
Patient age
disease severity plaque control patient compliance |
|
Systemic and Environmental Factors
|
Smoking
Systemic disease or condition Genetic Factors |
|
Air Polishing
(Contraindications) |
Respiratory illness
Hypertension Sodium restricted diets (due to sodium bicarbonate) Medications affecting electrolyte balance |
|
Local Factors
|
Plaque and calculus
Subgingival restorations Anatomic Factors |
|
Anatomic Factors
|
Short, Tapered roots
Cervical enamel projections Enamel pearls Bifurcation ridges Root concavity Developmental grooves Root Proximity Furcation involvement |
|
Prosthetic and Restorative Factors
|
Abutment selection
Caries Non-vital teeth Root resorption |
|
Perioscopy
(Periodontal Endoscope) |
-Statistically significant improvement in calculus removal during SRP, which was most evident in deeper PD sites
-Another study found no significant improvement in calculus removal in multirooted molar teeth |
|
Clinical Outcome of SRP Treatment
|
1. Gingival Recession
2. Reduction of PD & slight gain in CAL 3. Reduced BOP 4. Radiographic bone fill |
|
Excellent Prognosis
|
No bone loss
Excellent gingival condition Good patient cooperation No systemic or environmental factors |
|
What causes Reduction of Probing Depth?
|
1. Shrinkage of swollen tissue (no more inflammation)
2. Long Junctional Epithelium formation no longer allows deep probe penetration |
|
Good Prognosis
|
One or more of the following:
Adequate remaining bone support Adequate possibilites to control etiologic factors and maintainable dentition Adequate pt cooperation No systemic or environmental factors Systemic factors if present are well controlled |
|
Fair Prognosis
|
One or more of the following:
Less than adequate remaining bone support Some tooth mobility Grade I furcation Adequate maintenance possible Acceptable pt cooperation Presence of systemic or environmental factors |
|
Poor Prognosis
|
One or more of the following:
moderate to advanced bone loss tooth mobility Grade I, II furcation involvements Difficult to maintain areas Doubtful pt cooperation Presence of systemic or environmental factors |
|
Questionable Prognosis
|
One or more of the following:
Advanced bone loss Tooth Mobility Grade II, III furcation Inaccessible areas Presence of systemic or environmental factors |
|
Hopeless Prognosis
|
One or More of the following conditions:
Advanced bone loss Non-maintainable areas Extractions indicated Presence of uncontrolled systemic or environmental factors |
|
Plaque and Oral Hygeine
|
Qualitative VS Quantitative
Periodic Removal/Disruption Habits |
|
Root Anatomy & Furcation Involvement
|
Increased root separation = increased area for attachment
Less favorable short and long term if furcation is exposed Difficult area for patient to keep clean Difficult to treat periodontally |
|
Crown to root ratio
|
increased crown to root ratio=decreased prognosis
|
|
Restorations/ Structural Anomalies
|
Iatrogenic: Overhangs, biologic width Violations
Developmental: root proximity, enamel pearls, enamel projections |
|
Rate of Bone Loss
|
Variable, influenced by local hygiene, tooth anatomy, iatrogenic factors
Increased rate of bone loss = decreased prognosis |
|
Etiology of Mobility
|
Loss of attachment
Inflammation Occlusal Trauma Increased mobility=decreased prognosis |
|
Importance of Tooth
|
Prognosis of strategic teeth linked to restorative potential and periodontal support
|
|
How long does it take a healthy individual to develop Gingivitis?
|
~15-21 days
|
|
How long does it take for an individual to get back to good oral health?
|
~7-10 days
|
|
Initial Periodontal Therapy
|
-Patient education & motivation
-OHI/daily antimicrobials -Scaling & root planing combined or not combined with antimicrobials -Removal of additional retention factors for plaque (i.e.restoration overhangs, ill-fitting crowns, etc) -Minor restorative work -Extraction of hopeless teeth |
|
Criteria for Periodontal Surgery
|
Gingivitis & Slight Periodontitis = No Surgery; OHI & ScRP
Moderate Periodontitis = OHI & ScRP; Surgery (?) Severe Periodontitis = OHI & ScRP; Surgery |
|
Mechanical Plaque Control
|
-BEST APPROACH for the prevention & treatment of Gingivitis
-Prevention of gingivitis requires only METICULOUS removal of plaque every 48 hours -No more than 60% of the overall plaque is removed at each episode of oral hygiene -the MAIN benefit of 2X/day oral hygiene is the CHEMICAL ACTION of the DENTIFRICE -Studies show that gingival health improves with up to 2X/day brushing, but not more frequently |
|
Mechanical Plaque Control
(Toothbrush Design) |
-Long contoured handle performed better than short & flattened
-Small head size is best -Arrangement & height of filaments do no matter. High filament density is more effective. |
|
Powered Toothbrushes
|
-Higher compliance (62% of participants in on study showed continued daily use for 36 months)
-May removed 84% of the plaque in 2 minutes & 93% in 6 minutes -In a study, Plaque & Gingivitis reduction were only shown in Rotation oscillation brushes (OralB) |
|
Clinical Studies on Oral Hygiene
|
-Lack of reinforcement of oral hygiene over time increased poor compliance
-2-10% of the population floss regularly & effectively -A substantial part of the population never floss at all -Patient's average brushing time is 37 seconds -Only 10% of the population floss daily -Only 20% of the patients regularly perform acceptable flossing |
|
Irrigation Devices
|
-1,200 pulsations/minute with pressure of 55-90 psi reduces bleeding & gingivitis
-Many patients think this is a substitute for flossing (it is NOT) -Does NOT removed Plaque |
|
Dentifrice
(ADA Approval) |
An agent with antiplaque activity must have demonstrated a significant benefit on gingival health in randomized controlled studies of at least 6 months duration to receive approval by the ADA
|
|
Dentifrices
(Main Components) |
-Mild abrasiveness --> to remove debris & residual surface stains (ex: calcium carbonate, dehydrated silica gels, hydrated aluminum oxides, magnesium carbonate, phosphate salts & silicates)
-Fluoride --> to remineralized tooth (All ADA-Accepted toothpastes contain fluoride) -Humectants --> to prevent water loss (ex: glycerol, propylene, glycol & sorbitol) -Flavoring agents -Thickening agents --> to stabilize the formula -Detergents --> to create foaming action |
|
Antimicrobial Mouthrinses
|
-Biofilm cannot be suppressed by mechanical methods only (for most pts)
-Evidence supports the adjunctive use of mouthrinses on a daily basis |
|
Meta-Analysis
|
Systematic review of literature to evaluate the efficacy of antigingivitis & antiplaque products in 6 months trials
|
|
Meta-Analysis for Dentifrices
|
-17 studies support antiplaque, antigingivitis effects of dentifrices containing 0.30% triclosan & 2.0% gantrez copolymer
-No evidence of efficacy for triclosan with either soluble pyrophosphate or zinc citrate -Stannous fluoride has a marginal clinical significance as an antiplaque agent, but is both clinically & statistically significant as an antigingivitis agent |
|
Meta-Analysis for Mouthrinses
|
-21 studies support essential oils as efficacious mouthrinses
-7 studies support a strong antiplaque, antigingivitis effect for 0.12% Chlorhexidine -Results for cetylpyridinium chloride vary & depend on the product's formula |
|
Scaling
|
Instrumentation of crowns & root surfaces of the teeth to remove plaque, calculus & stains from these surfaces
|
|
Root Planing
|
A treatment procedure designed to remove cementum or surface dentin that is rough, impregnated with calculus, or contaminated wiht toxins & microorganisms
|
|
Scaling & Root Planing: Rationale
|
-Smooth surfaces are easier to clean & maintain
-Less potential to accumulate plaque & calculus -To eliminate biologically-incompatible cementum/dentin (cementum-bound endotoxin) -To make root surfaces biologically compatible for healing & long-term care |
|
Removal of Calculus
|
-Sites with PD>5mm have consistently shown remaining calculus after "closed" ScRP
-Surgically treated sites have shown improved efficacy of ScRP |
|
Other Factors of Calculus Removal
|
Root Anatomy:
-Single-rooted vs. multirooted -Concavities -Tooth furrows Skill of the operatore -Experience becomes more relevant in deep PD>6mm sites Time allowed: -Hand instruments: 6-8 min/tooth -Ultrasonic instruments: 4-6 min/tooth |
|
Ultrasonic & Sonic Scalers
|
-Outcome: uneven root surface
-Supplement with hand instrumentation for smoother surface -4-7mm pockets responded equally well to ultrasonic vs. hand instruments |
|
Results After ScRP
If Initial Probing Depth <3mm (Non-Molar Sites) |
Probing Depth Reduction = 0.5mm
Attachment Change = -0.5mm |
|
Results After ScRP
If Initial Probing Depth 3-6mm (Non-Molar Sites) |
Probing Depth Reduction = 1.0 - 1.5mm
Attachment Change = -0.5/+0.5mm |
|
Results After ScRP
If Initial Probing Depth 7-10+mm (Non-Molar Sites) |
Probing Depth Reduction = 2.5 - 5.0mm
Attachment Change = +0.5/+2.0mm |
|
Full-Mouth Disinfection (FMD)
|
-Moretti says is does NOT work to add FMD
|
|
Systemic Antibiotics in Periodontics
|
-For common forms of gingivitis & periodontitis, ScRP should always be carried out before antibiotics are administered
-Development of resistant bacterial strains is a major concern in medicine |
|
Systemic Antibiotics in Periodontics
(Main Indications) |
Refractory Cases (no response to tx)
Aggressive Periodontitis Medical conditions (i.e. Diabetes) Acute periodontal infections (abscess, NUG/NUP) Periodontal Regeneration Surgeries Implant Dentistry Post-surgical infections |
|
Selection of Antibiotics
|
-Travels easily to infection site
-Concentration in GCF, gingiva & bone -Minimal side effects -Research showing efficacy -Microbiological Culture & Sensitivity Test? |
|
Penicillin
|
Bactericidal
|
|
Tetracycline
|
Bacteriostatic
|
|
Minocycline
|
Bacteriostatic
|
|
Doxycycline
|
Bacteriostatic
|
|
Metronidazole
|
Bactericidal
|
|
Clindamycin
|
Usually Bacteriostatis
Bactericidal in high doses |
|
Ciprofloxacin
|
Bactericidal
|
|
Azithromycin
|
Bacteriostatic
|
|
Combination Therapy
(Advantages) |
-Broadens antimicrobial range of the therapeutic regimen of a single antibiotic
-Prevents emergence of resistant bacteria through overlapping antimicrobial mechanisms -Lowers the dose of individual antibiotics by exploiting possible synergy between 2 drugs |
|
Combination Therapy
(Disadvantages) |
-May increase adverse reactions
-Potential for antagonist drug interactions with improperly selected antibiotics |
|
Combination Therapy
|
-DO NOT combine bactericidal with bacteriostatic (cancels the effects of both)
-Most common = Amoxicillin + Metronidazole -Augmentin + Doxycyclin (Must be used SEQUENTIAL) -Ciprofloxacin - Metronidazole |
|
Conclusions on Systemic Antibiotics
|
-In periodontics, systemic antibiotics should be an exception rather than the rule
-If indicated, they should be used as adjuncts to mechanical therapy -They should not be used in cases of poor plaque control -Evidence has shown that they offer little, it any, adjunctive effect on smokers -Considered especially in refractory & aggressive cases of periodontitis (also in acute conditions & some medical situations) -Current trend favoring combined antibiotic therapy |
|
Topical Antimicrobial Agents
|
-Pathogens may be unreachable (furcation, dentin tubules, biofilm, deep vertical defects)
-Local delivery (Pocket irrigation, drug ointment/gel, prolonged release) -The average patient MAY have PD REDUCED 1mm -No significant change in CAL; BOP reduced 50% on average -Up to the clinician if they want to use these products |
|
Subgingival Irrigation
|
-Washed out rapidly by the GCF
-Half-life of a non-binding drug is 1 minute -Levels don't reach the MIC (Minimal Inhibitory Concentration) for oral microorganisms -Chlorhexidine & tetracycline (high substantivity) |
|
Supragingival Irrigation
|
Will not reach deeper parts of the pocket
|
|
Local Delivery Devices should
|
-Establish a drug reservoir
-Have effective concentration -Be active for prolonged period of time -UNC SOD uses "Arestin" |
|
Periodontium Pro-Inflammatory Mediators
|
IL-1Beta
IL-6 TNF-alpha PGE2 MMPs |
|
Host Modulators
|
-NSAIDs
-Bisphosphonates? -Statins? -Low-Dose Doxycycline |
|
Periodontium Natural Enzyme Inhibitors
|
TGF-Beta
IL-4 IL-10 IL-12 TIMPs |
|
Pathogenesis of Periodontal Disease
(Smokers) |
Chronic Overproduction of Tissue Destructive Enzymes (Bone Loss, Deeper Pockets are Greatly Affected)
-Studies show smokers have less favorable response to traditional modes of periodontal therapy -Smoking INCREASES levels of pro-inflammatory mediators; INCREASE release of DESTRUCTIVE COLLAGENASE -Periostat DECREASES pro-inflammatory mediators & collagenase |
|
What is the ONLY drug available to help PREVENT periodontitis?
|
PERIOSTAT (Doxycycline Hyclate)
|
|
How does PERIOSTAT work?
|
Subantimicrobial agent - Does not reach the Minimal Inhibitory Concentration in the blood to kill bacteria.
A small amount of the drug changes the immune response of MMPs & alters the disease progression to help reduce the rate of destruction of the periodontium -Should be taken 2X/day for 3-9 months (very costly) -Studies show statistically significant improvement with respect to PD reductions & gains in CAL when compared to ScRP alone. |
|
|
|
|
|
|